Congestive hepatic fibrosis score: a novel histologic assessment of clinical severity

Dao-Fu Dai1, Paul E Swanson1, Eric V Krieger2

  • 1Department of Pathology, University of Washington School of Medicine, Seattle, WA, USA.

Insights

A new grading system for congestive hepatic fibrosis was developed. This score correlates with right heart pressure and dilation, indicating its usefulness in assessing chronic heart failure severity.

Area of Science:

  • Cardiology
  • Hepatology
  • Pathology

Background:

  • Chronic right heart failure causes liver congestion and fibrosis (cardiac sclerosis).
  • Existing studies lack a standardized grading system for congestive hepatopathy.
  • Histologic features include sinusoidal dilatation and centrizonal necrosis.

Purpose of the Study:

  • To develop and validate a novel grading system for congestive hepatic fibrosis.
  • To correlate the proposed fibrosis score with right heart structure and function.
  • To assess the clinical utility of the grading system in patients with chronic heart failure.

Main Methods:

  • Analysis of 42 liver biopsies from patients with chronic heart failure of diverse etiologies.
  • Exclusion of cases with other chronic liver diseases, significant steatosis, or acute heart failure.
  • Correlation of a novel congestive hepatic fibrosis score with echocardiography and/or right heart catheterization data.

Main Results:

  • The congestive hepatic fibrosis score strongly correlates with right atrial pressure (P < 0.001).
  • Portal fibrosis (scores 2-3) is linked to significantly higher right atrial pressure compared to no or centrizonal fibrosis.
  • The score also associates with right atrial and ventricular dilatation, indicating chronic overload.

Conclusions:

  • A novel congestive hepatic fibrosis score effectively quantifies fibrosis severity in chronic heart failure.
  • Portal fibrosis indicates advanced disease and correlates with impaired right heart function.
  • This scoring system serves as a valuable indicator of clinical severity in congestive hepatopathy.

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
26
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
34
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
380
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
1.3K
Liver Histology01:27

Liver Histology

The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
10.7K